Potential drug interactions in elderly cancer patients

Critical Reviews in Oncology/Hematology

Volumn 78, Issue 3, 2011, Pages 220-226

  Girre, V ^a   Arkoub, H ^a   Puts, M T E ^b   Vantelon, C ^a,c   Blanchard, F ^d   Droz, J P ^e   Mignot, L ^a  

^a INSTITUT CURIE   (France)

^b UNIVERSITY OF TORONTO   (Canada)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d REIMS UNIVERSITY HOSPITAL   (France)

^e CENTRE LÉON BÉRARD   (France)

Author keywords

Cancer; Drug interactions; Drug therapy; Elderly; Polypharmacy

Indexed keywords

ANALGESIC AGENT; BETAHISTINE; HYDROXYZINE;

AGED; CANCER PATIENT; DRUG ANTAGONISM; DRUG CONTRAINDICATION; FEMALE; GERIATRIC ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYPHARMACY; RESPIRATORY DISTRESS; REVIEW; RISK ASSESSMENT; SEDATION; SIDE EFFECT;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DRUG INTERACTIONS; HUMANS; NEOPLASMS;

EID: 79955650594     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2010.05.004     Document Type: Review

References (50)

1. Yancik R., Ganz P.A., Varricchio C.G., Conley B. Perspectives on comorbidity and cancer in older patients: approaches to expand the knowledge base. J Clin Oncol 2001, 19(February (4)):1147-1151.
2. Jorgensen T., Johansson S., Kennerfalk A., Wallander M.A., Svardsudd K. Prescription drug use, diagnoses, and healthcare utilization among the elderly. Ann Pharmacother 2001, 35(September (9)):1004-1009.
3. Legrain S. Prescription to elderly patients: reducing underuse and adverse drug reactions and improving adherence. Bull Acad Natl Med 2007, 191(February (2)):259-269. discussion 69-70.
4. Riechelmann R.P., Moreira F., Smaletz O., Saad E.D. Potential for drug interactions in hospitalized cancer patients. Cancer Chemother Pharmacol 2005, 56(September (3)):286-290.
5. Sokol K.C., Knudsen J.F., Li M.M. Polypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect management. J Clin Pharm Ther 2007, 32(April (2)):169-175.
6. Girre V., Falcou M.C., Gisselbrecht M., et al. Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients?. J Gerontol A: Biol Sci Med Sci 2008, 63(July (7)):724-730.
7. Dergal J.M., Gold J.L., Laxer D.A., et al. Potential interactions between herbal medicines and conventional drug therapies used by older adults attending a memory clinic. Drugs Aging 2002, 19(11):879-886.
8. Spinewine A., Schmader K.E., Barber N., et al. Appropriate prescribing in elderly people: how well can it be measured and optimised?. Lancet 2007, 370(July (9582)):173-184.
9. Bouchardy C., Rapiti E., Blagojevic S., Vlastos A.T., Vlastos G. Older female cancer patients: importance, causes, and consequences of undertreatment. J Clin Oncol 2007, 25(May (14)):1858-1869.
10. Green J.L., Hawley J.N., Rask K.J. Is the number of prescribing physicians an independent risk factor for adverse drug events in an elderly outpatient population?. Am J Geriatr Pharmacother 2007, 5(March (1)):31-39.
11. Tamblyn R.M., McLeod P.J., Abrahamowicz M., Laprise R. Do too many cooks spoil the broth? Multiple physician involvement in medical management of elderly patients and potentially inappropriate drug combinations. CMAJ 1996, 154(April (8)):1177-1184.
12. McLean A.J., Le Couteur D.G. Aging biology and geriatric clinical pharmacology. Pharmacol Rev 2004, 56(June (2)):163-184.
13. Tulner L.R., Kuper I.M., Frankfort S.V., et al. Discrepancies in reported drug use in geriatric outpatients: relevance to adverse events and drug-drug interactions. Am J Geriatr Pharmacother 2009, 7(April (2)):93-104.
14. Stewart R.B., Cooper J.W. Polypharmacy in the aged. Practical solutions. Drugs Aging 1994, 4(June (6)):449-461.
15. Bepko R.J., Moore J.R., Coleman J.R. Implementation of a pharmacy automation system (robotics) to ensure medication safety at Norwalk hospital. Qual Manag Health Care 2009, 18(April-June (2)):103-114.
16. Gurwitz J.H., Field T.S., Rochon P., et al. Effect of computerized provider order entry with clinical decision support on adverse drug events in the long-term care setting. J Am Geriatr Soc 2008, 56(December (12)):2225-2233.
17. Spinewine A., Swine C., Dhillon S., et al. Effect of a collaborative approach on the quality of prescribing for geriatric inpatients: a randomized, controlled trial. J Am Geriatr Soc 2007, 55(May (5)):658-665.
18. Beers M.H., Ouslander J.G., Rollingher I., Reuben D.B., Brooks J., Beck J.C. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 1991, 151(September (9)):1825-1832.
19. Aparasu R.R., Mort J.R. Inappropriate prescribing for the elderly: beers criteria-based review. Ann Pharmacother 2000, 34(March (3)):338-346.
20. Naugler C.T., Brymer C., Stolee P., Arcese Z.A. Development and validation of an improving prescribing in the elderly tool. Can J Clin Pharmacol 2000, 7(Summer (2)):103-107.
21. van der Hooft C.S., Jong G.W., Dieleman J.P., et al. Inappropriate drug prescribing in older adults: the updated 2002 Beers criteria - a population-based cohort study. Br J Clin Pharmacol 2005, 60(August (2)):137-144.
22. Gallagher P., O'Mahony D. STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria. Age Ageing 2008, 37(November (6)):673-679.
23. O'Mahony D., Gallagher P.F. Inappropriate prescribing in the older population: need for new criteria. Age Ageing 2008, 37(March (2)):138-141.
24. Fick D.M., Cooper J.W., Wade W.E., Waller J.L., Maclean J.R., Beers M.H. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003, 163(December (22)):2716-2724.
25. Lechevallier-Michel N., Gautier-Bertrand M., Alperovitch A., et al. Frequency and risk factors of potentially inappropriate medication use in a community-dwelling elderly population: results from the 3C Study. Eur J Clin Pharmacol 2005, 60(January (11)):813-819.
26. Blower P., de Wit R., Goodin S., Aapro M. Drug-drug interactions in oncology: why are they important and can they be minimized?. Crit Rev Oncol Hematol 2005, 55(August (2)):117-142.
27. Riechelmann R.P., Tannock I.F., Wang L., Saad E.D., Taback N.A., Krzyzanowska M.K. Potential drug interactions and duplicate prescriptions among cancer patients. J Natl Cancer Inst 2007, 99(April (8)):592-600.
28. Riechelmann R.P., Zimmermann C., Chin S.N., et al. Potential drug interactions in cancer patients receiving supportive care exclusively. J Pain Symptom Manage 2008, 35(May (5)):535-543.
29. Bjerrum L., Andersen M., Petersen G., Kragstrup J. Exposure to potential drug interactions in primary health care. Scand J Prim Health Care 2003, 21(September (3)):153-158.
30. Riechelmann R.P., Saad E.D. A systematic review on drug interactions in oncology. Cancer Invest 2006, 24(November (7)):704-712.
31. Kennerfalk A., Ruigomez A., Wallander M.A., Wilhelmsen L., Johansson S. Geriatric drug therapy and healthcare utilization in the United kingdom. Ann Pharmacother 2002, 36(May (5)):797-803.
32. Kaufman D.W., Kelly J.P., Rosenberg L., Anderson T.E., Mitchell A.A. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 2002, 287(January (3)):337-344.
33. Viktil K.K., Blix H.S., Moger T.A., Reikvam A. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol 2007, 63(February (2)):187-195.
34. Rollason V., Vogt N. Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist. Drugs Aging 2003, 20(11):817-832.
35. Barat I., Andreasen F., Damsgaard E.M. The consumption of drugs by 75-year-old individuals living in their own homes. Eur J Clin Pharmacol 2000, 56(September (6-7)):501-509.
36. Doucet J., Queneau P. Adverse drug reactions in the elderly. Bull Acad Natl Med 2005, 189(November (8)):1693-1707. discussion 708-9.
37. Frazier S.C. Health outcomes and polypharmacy in elderly individuals: an integrated literature review. J Gerontol Nurs 2005, 31(September (9)):4-11.
38. Shi S., Morike K., Klotz U. The clinical implications of ageing for rational drug therapy. Eur J Clin Pharmacol 2008, 64(February (2)):183-199.
39. Budnitz D.S., Pollock D.A., Weidenbach K.N., Mendelsohn A.B., Schroeder T.J., Annest J.L. National surveillance of emergency department visits for outpatient adverse drug events. JAMA 2006, 296(October (15)):1858-1866.
40. Doucet J., Chassagne P., Trivalle C., et al. Drug-drug interactions related to hospital admissions in older adults: a prospective study of 1000 patients. J Am Geriatr Soc 1996, 44(August (8)):944-948.
41. Puts M.T., Costa-Lima B., Monette J., et al. Medication problems in older, newly diagnosed cancer patients in Canada: how Common are they?: a prospective pilot study. Drugs Aging 2009, 26(6):519-536.
42. Leipzig R.M., Cumming R.G., Tinetti M.E. Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc 1999, 47(January (1)):30-39.
43. Herrlinger C., Klotz U. Drug metabolism and drug interactions in the elderly. Best Pract Res Clin Gastroenterol 2001, 15(December (6)):897-918.
44. Aubert R.E. Risk of breast cancer recurrence in women initiating tamoxifen with CYP2D6 inhibitors. J Clin Oncol 2009, 27(18s). abstr CRA 508.
45. Dezentje V. Concomitant CYP2D6 inhibitor use and tamoxifen adherence in early-stage breast cancer: a pharmacoepidemiologic study. J Clin Oncol 2009, 27(18s). abstr CRA 509.
46. Lichtman S.M., Boparai M.K. Anticancer drug therapy in the older cancer patient: pharmacology and polypharmacy. Curr Treat Options Oncol 2008, 9(June (2-3)):191-203.
47. Tranchand B., Laporte S., Glehen O., Freyer G. Pharmacology of cytotoxic agents: a helpful tool for building dose adjustment guidelines in the elderly. Crit Rev Oncol Hematol 2003, 48(November (2)):199-214.
48. Extermann M., Chen H., Cantor A.B., et al. Predictors of tolerance to chemotherapy in older cancer patients: a prospective pilot study. Eur J Cancer 2002, 38(July (11)):1466-1473.
49. Relling M.V., Pui C.H., Sandlund J.T., et al. Adverse effect of anticonvulsants on efficacy of chemotherapy for acute lymphoblastic leukaemia. Lancet 2000, 356(July (9226)):285-290.
50. Clement J.P., Nassif R.F., Leger J.M., Marchan F. Development and contribution to the validation of a brief French version of the Yesavage Geriatric Depression Scale. Encephale 1997, 23(March-April (2)):91-99.